IP Verse

Animal Models And Therapeutic Molecules

Patent No. EP3622813 (titled "Animal Models And Therapeutic Molecules") was filed by Kymab on Jul 7, 2010. The application was issued on Jun 19, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
REGENERON PHARMACEUTICALSFeb 18, 2021J A KEMP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3622813

KYMAB
Application Number
EP19207050A
Filing Date
Jul 7, 2010
Status
Patent Maintained As Amended
May 17, 2024
Publication Date
Jun 19, 2024
External Links
Slate, Register , Google Patents